Related Experiment Video
Updated: Oct 23, 2025

IridiumIII Luminescent Probe for Detection of the Malarial Protein Biomarker Histidine Rich Protein-II
Published on: July 7, 2015
Binding of histidine and human serum albumin to dirhodium(II) tetraacetate
Farideh Jalilehvand1, Alejandra Enriquez Garcia1, Pantea Niksirat1
1Department of Chemistry, University of Calgary, Calgary, AB T2N 1N4, Canada.
Abstract:
Reactions of the anticancer active dirhodium tetraacetate (1), Rh2(AcO)4 (AcO- = CH3COO-), with the amino acid histidine (HHis) and human serum albumin (HSA) were monitored over time and different metal: ligand ratios using UV-vis spectroscopy and/or electro-spray ionization mass spectrometry. Initially, histidine formed 1:1 and 1:2 adducts in aqueous solutions. The crystal structure of Rh2(AcO)4(L-HHis)2·2H2O (2) confirmed the axial coordination of histidine imidazole groups (average Rh-Naxial 2.23 Å). These adducts, however, were found to be unstable in solution over time (24 h). Heating Rh2(AcO)4 -histidine solutions to 40 °C (near body temperature) or 95 °C accelerated the formation of RhII2(AcO)2(His)2 and RhIII(His)2(AcO) complexes. The corresponding pH change from neutral to mildly acid (pH 4-5) indicates deprotonation of histidine NH3+ groups due to coordination to Rh ions, which simultaneously bind to histidine COO- groups, as evidenced by 13C NMR spectroscopy. In the case of HSA with 16 histidine and one cysteine residues, UV-vis spectroscopy indicates that mono- and di-histidine HSA adducts with Rh2(AcO)4 are formed. X-ray absorption spectroscopy showed almost the same Rh-Rh distance (2.41 ± 0.01 Å) for the Rh2(AcO)4 units as in 2, and a contribution from an axial thiol coordination (Rh-Saxial 2.62 ± 0.05 Å). The Rh2(AcO)4 - HSA complex was found to decompose partially (~15%) over 24 h at ambient temperature. The partial decomposition of Rh2(AcO)4 both through coordination to histidine or to human serum albumin, the most abundant protein in blood plasma, is a factor to consider for its efficacy as a potential anticancer agent.

